Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise Ultrasound Renal Denervation (RDN) system for the treatment of hypertension.

News | FDA

First FDA Approval of Renal Denervation System to Treat Hypertension Announced by Recor Medical and Otsuka Medical Devices

November 8, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the U ...

November 08, 2023

The results come from a national study of more than 1 million U.S. hospital admissions among young adult tobacco users without other known cardiovascular risk factors

News | Stroke

Prediabetes and Persistent Tobacco Use May Triple Risk of Stroke in Healthy Young Adults

November 8, 2023 — The combination of persistent tobacco use and prediabetes (higher than normal blood sugar levels that ...

November 08, 2023

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

News | FDA

Teleflex, and Arrow International, Recall Pressure Injectable Catheter Kits for Mislabeling

November 7, 2023 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and its subsidiary Arrow ...

November 07, 2023

Here's a look at what viewers found most interesting during the month of October on dicardiology.com

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: What Viewers Were Reading in October

As another month comes to a close, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com ...

November 06, 2023

Marlene Rabinovitch, MD, Stanford University

News | AHA

Dr. Marlene Rabinovitch to Receive the 2023 AHA Research Achievement Award

November 3, 2023 — The American Heart Association will present its 2023 Research Achievement Award to Marlene ...

November 03, 2023

New Board of Cardiovascular Medicine will certify cardiovascular medicine physicians with more specific and more competency-based trainings and supports

News | Heart Failure

The American Heart Association Joins Consortium with Full Support for a New American Board of Cardiovascular Medicine

November 3, 2023 — The national Board of Directors of the American Heart Association last week voted to provide full ...

November 03, 2023

News | VIVA

Data from VIVA23 Late-breaking Clinical Trial Focuses on Computer-Assisted Vacuum Thrombectomy for Pulmonary Embolism

November 2, 2023 — The latest STRIKE-PE data, presented by Penumbra, Inc. at the Vascular Interventional Advances ...

November 02, 2023

News | VIVA

Late-Breaking Clinical Trial outcomes from The VEINS Conference: CLOUT Registry, VIVID Trial, DEXTERITY-AFP Trial, and Venous Thromboembolism Treatment

October 31, 2023 — Results of four late-breaking clinical trials presented during the The VEINS Conference 2023, taking ...

October 31, 2023

Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two contemporary mitral transcatheter edge-to-edge repair (TEER) therapies

News | Structural Heart

CLASP IID One-year Data Confirm Safety and Efficacy of Edwards Pascal System for Degenerative Mitral Regurgitation

October 31, 2023 — Edwards Lifesciences Corporation announced one-year results from CLASP IID, the first randomized ...

October 31, 2023

The findings will impact the interventional treatment of High Bleeding Risk patients

News | Ventricular Assist Devices (VAD)

Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...

October 31, 2023

Key findings demonstrate patients with aortic stenosis have substantial untreated mortality risk across all levels of aortic stenosis severity, but aortic valve replacement rates remain low even for patients with severe aortic stenosis

News | Endovascular Aortic Repair

Philippe Généreux, MD Presents Novel Research on Aortic Stenosis from egnite, Inc.’s Database at TCT23

October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research ...

October 30, 2023

New data presented at Transcatheter Cardiovascular Therapeutics (TCT) 2023 from the TRILUMINATE pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid regurgitation (a leaky valve) with TriClip, an investigational device in the US

News | Structural Heart

Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive ...

October 26, 2023

News | TCT

Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons

October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued ...

October 26, 2023

News | TCT

New Study Reveals Inequities in Access to Mechanical Circulatory Support in US Patients with Cardiogenic Shock

October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in ...

October 25, 2023

News | TCT

Six-Month Clinical Data from DESyne BDS Plus Randomized Controlled Trial (RCT) Presented at TCT 2023 Shines Spotlight on Safety, Effectiveness of World’s First Site-Specific Antithrombotic Drug Therapy

October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical ...

October 25, 2023

Webinars

ON-DEMAND Webinar: Maximizing Structural Heart Workflows

NOW AVAILABLE ON DEMAND: Contrast Management in Modern PCI

Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery.

WEBINAR NOW AVAILABLE ON DEMAND: Improving Patient Outcomes and Reducing Contrast Utilization in the Cath Lab

VIDEOS

ON-DEMAND Webinar: Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

ON-DEMAND WEBINAR: Maximizing Structural Heart Workflows

BLOGS

Vamsi S. Krishna, MD, Interventional Cardiology Specialist, Ascension Seton Edgar B. Davis and Ascension Seton Hays

BLOG: Enhancing Efficiency and Patient Care with a Modern Injector

Maureen Gardner, Senior Clinical Product Manager

BLOG: The Power of Enterprise Imaging in Structural Heart Procedures

Melinda Taschetta-Millane, Editorial Director

Enhancing the Educational Experience